Abstract:In glucose transporter 1 deficiency syndrome (Glut1DS), glucose transport into brain is reduced due to impaired Glut1 function in endothelial cells at the blood–brain barrier. This can lead to shortages of glucose in brain and is thought to contribute to seizures. Ketogenic diets are the first‐line treatment and, among many beneficial effects, provide auxiliary fuel in the form of ketone bodies that are largely metabolized by neurons. However, Glut1 is also the main glucose transporter in astrocytes. Here, we review data indicating that glucose shortage may also impact astrocytes in addition to neurons and discuss the expected negative biochemical consequences of compromised astrocytic glucose transport for neurons. Based on these effects, auxiliary fuels are needed for both cell types and adding medium chain triglycerides (MCTs) to ketogenic diets is a biochemically superior treatment for Glut1DS compared to classical ketogenic diets. MCTs provide medium chain fatty acids (MCFAs), which are largely metabolized by astrocytes and not neurons. MCFAs supply energy and contribute carbons for glutamine and γ‐aminobutyric acid synthesis, and decanoic acid can also block α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid glutamate receptors. MCTs do not compete with metabolism of ketone bodies mostly occurring in neurons. Triheptanoin, an anaplerotic but also gluconeogenic uneven MCT, may be another potential addition to ketogenic diets, although maintenance of "ketosis" can be difficult. Gene therapy has also targeted both endothelial cells and astrocytes. Other approaches to increase fuel delivery to the brain currently investigated include exchange of Glut1DS erythrocytes with healthy cells, infusion of lactate, and pharmacological improvement of glucose transport. In conclusion, although it remains difficult to assess impaired astrocytic energy metabolism in vivo, astrocytic energy needs are most likely not met by ketogenic diets in Glut1DS. Thus, we propose prospective studies including monitoring of blood MCFA levels to find optimal doses for add‐on MCT to ketogenic diets and assessing of short‐ and long‐term outcomes.

The interplay between glucose and ketone bodies in neural stem cell metabolism

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Sugar for the brain: the role of glucose in physiological and pathological brain function

Glucose metabolic crosstalk and regulation in brain function and diseases

Impact of Metabolic Pathways and Epigenetics on Neural Stem Cells

Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders.

Case for supporting astrocyte energetics in glucose transporter 1 deficiency syndrome

Emerging Functional Connections Between Metabolism and Epigenetic Remodeling in Neural Differentiation

Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury

Brain Metabolism in Health and Neurodegeneration: The Interplay Among Neurons and Astrocytes

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases

Mitochondrial metabolism in neural stem cells and implications for neurodevelopmental and neurodegenerative diseases

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Glucose sparing by glycogenolysis (GSG) determines the relationship between brain metabolism and neurotransmission

The role of hypoxia in stem cell regulation of the central nervous system: From embryonic development to adult proliferation

The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.

Fueling neurodegeneration: metabolic insights into microglia functions

β-Hydroxybutyrate Improves the Redox Status, Cytokine Production and Phagocytic Potency of Glucose-Deprived HMC3 Human Microglia-like Cells

Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation